Abstract
Studies have demonstrated that phosphodiesterase 5 (PDE5) inhibition is associated with right ventricle (RV) functional improvement in patients with primary pulmonary hypertension. This study aims to demonstrate the immediate impact of Sildenafil, a PDE5 inhibitor, on RV function, measured by cardiovascular magnetic resonance (CMR), in patients with heart failure (HF). We conducted a randomized double-blind controlled trial. diagnosis of HF functional class I-III; left ventricle ejection fraction < 35%. Patients underwent CMR evaluation and were then equally randomly assigned to either 50 mg of Sildenafil or Placebo groups. One hour following drug administration, they were submitted to a second scan examination. 26 patients were recruited from a tertiary reference center in Brazil and 13 were allocated to each study group. The median age was 61.5 years (50-66.5 years). Except for the increase in RV fractional area change following the administration of sildenafil (Sildenafil [before vs. after]: 34.3 [25.2-43.6]% vs. 42.9 [28.5-46.7]%, p = 0.04; Placebo [before vs. after]: 28.1 [9.2-34.8]% vs. 29.2 [22.5-38.8]%, p = 0.86), there was no statistically significant change in parameters. There was no improvement in left ventricular p...Continue Reading
References
Jul 15, 1996·Clinica Chimica Acta; International Journal of Clinical Chemistry·K P VorderwinklerH M Piper
Jan 25, 2005·Nature Medicine·Eiki TakimotoDavid A Kass
Apr 9, 2005·BMC Pharmacology·Madiha A H Hassan, Amal F Ketat
Nov 18, 2005·The New England Journal of Medicine·Nazzareno GalièUNKNOWN Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group
Dec 21, 2006·Circulation·Gregory D LewisMarc J Semigran
May 9, 2007·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Aasha S GopalNathaniel Reichek
Jul 4, 2007·Circulation·Jayan NagendranEvangelos D Michelakis
Sep 6, 2007·Circulation·Gregory D LewisMarc J Semigran
Jan 29, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Fadi N SalloumRakesh C Kukreja
Nov 14, 2008·European Journal of Heart Failure·Asger AndersenJens Erik Nielsen-Kudsk
Nov 26, 2008·Cardiovascular Research·Steven HsuEiki Takimoto
Jan 10, 2009·Journal of the American College of Cardiology·Takahiro NagayamaDavid A Kass
Oct 8, 2009·Circulation. Heart Failure·Gregory D LewisMarc J Semigran
Jan 6, 2010·Circulation·Philippe MeyerAli Ahmed
Jun 8, 2010·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Taco KindAnton Vonk-Noordegraaf
Aug 31, 2011·Progress in Cardiovascular Diseases·Francois HaddadVinicio de Jesus Perez
Nov 23, 2011·International Journal of Cardiology·Daniel DumitrescuStephan Rosenkranz
Dec 2, 2011·The Canadian Journal of Cardiology·Brian J PotterAnique Ducharme
Dec 3, 2011·Circulation. Heart Failure·Xiaoyin ShanKenneth B Margulies
Jun 26, 2012·European Journal of Heart Failure·Marinus A J BorgdorffRolf M F Berger
Oct 13, 2012·International Journal of Cardiology·Adrian ReichenbachVojtech Melenovsky
Citations
Dec 19, 2018·Circulation. Cardiovascular Imaging·Manish AggarwalGautam K Singh
Nov 14, 2019·British Journal of Pharmacology·Nikolaos TzoumasDavid J Webb
Dec 14, 2018·Expert Opinion on Investigational Drugs·Juan TamargoEva Delpón
Mar 8, 2018·BioMed Research International·Nabham RaiTatyana Novoyatleva